<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7020194\results\search\testTrace\results.xml">
  <result pre="to be taken into consideration for its utility as a" exact="screening" post="or prognostic tool in disease management and/or as a"/>
  <result pre="in disease management and/or as a therapeutic target for the" exact="treatment" post="of lung diseases. CD151 lung cancer asthma influenza idiopathic"/>
  <result pre="respiratory diseases are not curable in some cases and current" exact="treatment" post="options are suboptimal for the majority of patients with"/>
  <result pre="into consideration for its utility in disease management as a" exact="screening" post="or prognostic tool and as targeted or adjuvant therapy."/>
  <result pre="airway inflammation (Barnes, 1996; Kudo et al., 2013). Current asthma" exact="treatment" post="is mainly focused on long-term clinical control of asthma"/>
  <result pre="addition, CD151-null mice were more resistant and tolerant to IAV" exact="infection" post="with higher survival rates as compared to the wild-type"/>
  <result pre="on viral nuclear export signaling associated with H3N2 and H1N1" exact="infection" post="(Qiao et al., 2018) highlights the potential of CD151"/>
  <result pre="confirmed when CD151 levels were inhibited by HIF-1Î± induction through" exact="treatment" post="with desferrioxamine (hypoxia-mimetic agent) or overexpression with plasmid vectors"/>
  <result pre="these changes. In the study reporting CD151 mRNA downregulation after" exact="treatment" post="with anti-epileptic drugs, valproate and carbamazepine (Hua et al.,"/>
  <result pre="2008; Zevian et al., 2011). Also, the effect of drug" exact="treatment" post="on these post-translational modifications has not been elucidated. Besides"/>
  <result pre="invasive than traditional biopsy techniques. The potential of CD151 expression" exact="detection" post="in exosomes as a screening tool has been explored"/>
  <result pre="The potential of CD151 expression detection in exosomes as a" exact="screening" post="tool has been explored where a high level of"/>
  <result pre="in adenocarcinoma patients was observed (Sandfeld-Paulsen et al., 2016). Effective" exact="screening" post="methods are especially vital in NSCLC for which 60%"/>
  <result pre="remain to be explored, although its anti-cancer properties for the" exact="treatment" post="of lung cancer are promising. Besides the use of"/>
  <result pre="as a diagnostic biomarker which may be helpful for early" exact="detection" post="or screening, or as a prognostic biomarker given its"/>
  <result pre="development as a novel targeted or adjuvant therapy in the" exact="treatment" post="of respiratory diseases. Author Contributions AW and TT wrote"/>
  <result pre="Cancer Res.1195â€&quot;105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA. J. (2019). Nanotechnology in the" exact="diagnosis" post="and treatment of lung cancer.Pharmacol. Ther.198189â€&quot;205. 10.1016/j.pharmthera.2019.02.01030796927 DengX.LiQ.HoffJ.NovakM.YangH.JinH.et al."/>
  <result pre="10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA. J. (2019). Nanotechnology in the diagnosis and" exact="treatment" post="of lung cancer.Pharmacol. Ther.198189â€&quot;205. 10.1016/j.pharmthera.2019.02.01030796927 DengX.LiQ.HoffJ.NovakM.YangH.JinH.et al. (2012). Integrin-associated"/>
 </snippets>
</snippetsTree>
